-
-
-
-
-
-
-
Teva Pharma (TEVA) Tops Q4 EPS by 23c, offers outlook
-
-
-
-
-
-
-
Teva Pharma (TEVA) and Sanofi (SNY) Enter Exclusive Collaboration to Deliver Inflammatory Bowel Disease Treatment
-
-
-
-
-
-
-
Teva Pharma (TEVA) Misses Q1 EPS by 15c, Revenue Beats, Offers Guidance
-
-
-
-
-
-
-
Teva to Host Conference Call to Discuss Fourth Quarter and Full Year 2022 Financial Results and 2023 Financial Guidance at 8 a.m. ET on February 8, 2023
-
-
-
-
-
-
-
Teva to Host Conference Call to Discuss Third Quarter 2022 Financial Results at 8 a.m. ET on November 3, 2022
-
-
-
-
-
-
-
Teva Reports Second Quarter 2022 Financial Results
-
-
-
-
-
-
-
Immuneering Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Updates
-
976,652 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All